Related Experiment Video
Updated: Apr 12, 2026
06:30
Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
8.4K
Resuming anticoagulation after hemorrhage: A practical approach
Alison Colantino1, Amir K Jaffer2, Daniel J Brotman3
1Hospitalist Program, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Cleveland Clinic Journal of Medicine
|May 9, 2015
Summary
Patients on anticoagulant therapy who experience hemorrhage remain at risk for thrombosis. This paper provides a practical framework for individualizing anticoagulation resumption after bleeding events, addressing a gap in evidence-based guidelines.
Area of Science:
- Cardiology
- Hematology
- Clinical Medicine
Background:
- Patients on long-term anticoagulant therapy face a dual risk of recurrent bleeding and thrombosis after a hemorrhage.
- Current clinical practice lacks evidence-based guidelines for managing anticoagulation post-hemorrhage.
Purpose of the Study:
- To offer a practical framework for individualizing the resumption of anticoagulation therapy after a bleeding event.
- To guide physicians in balancing the risks of recurrent bleeding against the need for thrombotic event prevention.
Main Methods:
- This study proposes a clinical decision-making framework.
- The framework considers individual patient factors, bleeding severity, and thrombosis risk.
Main Results:
- A structured approach to anticoagulation management after hemorrhage is presented.
- The framework aims to optimize patient care by tailoring anticoagulation strategies.
Conclusions:
- Individualized assessment is crucial for determining the optimal timing and strategy for resuming anticoagulation after hemorrhage.
- The proposed framework addresses a critical unmet need in managing patients on anticoagulant therapy post-bleeding.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
01:29Venous Thrombosis III: Interprofessional Care
471
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
01:30Venous Thrombosis IV: Nursing Management
392
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
392
01:05Introduction to Hemostasis
17.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
17.9K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.7K